Drug Trial Radar · NCT05736224
Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen
Last checked: Nov 19, 2026Latest source record: Nov 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
May 15, 2023
Primary completion
Sep 1, 2023
Study completion Sep 1, 2023
Sponsor
- Lead sponsor
- Yale UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Feb 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the effects of a novel sunscreen formulation by assessing the extent of ultraviolet radiation (UVR)-induced direct and indirect cellular and DNA damage to human skin, in the presence vs absence of the sunscreen, in a population of healthy adults with fair skin (Fitzpatrick Scale type I, II or III).
Conditions
- Skin Cancer
Interventions
SunscreenDrug
The sunscreen contains bioadhesive nanoparticles (BNP) encapsulating avobenzone and octocrylene plus the non-toxic natural products diosmin, ferulic acid, cytisine and trans-resveratrol.
UV LightOther
UV light to the correct sites, and the Multiport 610 solar simulator used to deliver 1 MED UVR to the appropriate subsites.
Primary outcomes
What the sponsor says the trial is designed to measure.
- DNA Damage Level by Cyclobutane Pyrimidine Dimer (CPD) MeasurementTime frame: 5 minutes after UVR exposure
- DNA Damage Level by Cyclobutane Pyrimidine Dimer (CPD) MeasurementTime frame: 4 hours after UVR exposure
- Detectable DNA Strand BreaksTime frame: 5 minutes after UVR exposure
- Number of DNA Strand BreaksTime frame: 4 hours after UVR exposure
- Cellular DamageTime frame: 5 minutes after UVR exposure
- Cellular DamageTime frame: 4 hours after UVR exposure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Yale School of Medicine
New Haven, Connecticut
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.